38112003: 1 (kwalificatiewaarde)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
1 (kwalificatiewaarde)	Is a	General adjectival modifier	false	Inferred relationship	Some
1 (kwalificatiewaarde)	Is a	Number	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Tiludronic acid (as tiludronate disodium) 200 mg oral tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely tamoxifen (as tamoxifen citrate) 40 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely tamoxifen (as tamoxifen citrate) 40 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely nelfinavir (as nelfinavir mesilate) 625 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely nelfinavir (as nelfinavir mesilate) 625 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Meptazinol (as meptazinol hydrochloride) 200 mg oral tablet	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Meptazinol (as meptazinol hydrochloride) 200 mg oral tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely nebivolol (as nebivolol hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely nebivolol (as nebivolol hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Venlafaxine (as venlafaxine hydrochloride) 75 mg oral tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Venlafaxine (as venlafaxine hydrochloride) 75 mg oral tablet	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely varenicline (as varenicline tartrate) 1 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely varenicline (as varenicline tartrate) 1 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely varenicline (as varenicline tartrate) 1 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely cilazapril (as cilazapril monohydrate) 500 microgram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely cilazapril (as cilazapril monohydrate) 500 microgram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely amoxicillin (as amoxicillin trihydrate) 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely amoxicillin (as amoxicillin trihydrate) 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	2
Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely imatinib (as imatinib mesilate) 400 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely imatinib (as imatinib mesilate) 400 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Levothyroxine sodium anhydrous 75 microgram oral tablet	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Levothyroxine sodium anhydrous 75 microgram oral tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	2
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Levothyroxine sodium anhydrous 100 microgram oral tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Levothyroxine sodium anhydrous 100 microgram oral tablet	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Flucloxacillin (as flucloxacillin sodium) 500 mg oral capsule	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Flucloxacillin (as flucloxacillin sodium) 500 mg oral capsule	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Lofepramine (as lofepramine hydrochloride) 70 mg oral tablet	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Lofepramine (as lofepramine hydrochloride) 70 mg oral tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing only ravulizumab in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing only ravulizumab (medicinal product)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	2
Quinagolide (as quinagolide hydrochloride) 75 microgram oral tablet	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Quinagolide (as quinagolide hydrochloride) 75 microgram oral tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely levofloxacin (as levofloxacin hemihydrate) 250 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely levofloxacin (as levofloxacin hemihydrate) 250 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely ibandronic acid (as ibandronate sodium monohydrate) 50 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely ibandronic acid (as ibandronate sodium monohydrate) 50 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Salbutamol (as salbutamol sulfate) 4 mg oral tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Salbutamol (as salbutamol sulfate) 4 mg oral tablet	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	2
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely loxapine (as loxapine succinate) 10 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely loxapine (as loxapine succinate) 10 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely ampicillin (as ampicillin trihydrate) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely ampicillin (as ampicillin trihydrate) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	2
Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Levothyroxine sodium anhydrous 25 microgram oral capsule	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Levothyroxine sodium anhydrous 25 microgram oral capsule	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Pergolide (as pergolide mesilate) 250 microgram oral tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Pergolide (as pergolide mesilate) 250 microgram oral tablet	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely paroxetine (as paroxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely paroxetine (as paroxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely cisapride (as cisapride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely cisapride (as cisapride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	2
Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely quetiapine (as quetiapine fumarate) 150 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely quetiapine (as quetiapine fumarate) 150 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	2
Reboxetine (as reboxetine mesilate) 4 mg oral tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Reboxetine (as reboxetine mesilate) 4 mg oral tablet	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely loxapine (as loxapine succinate) 25 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely loxapine (as loxapine succinate) 25 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely pergolide (as pergolide mesilate) 1 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely pergolide (as pergolide mesilate) 1 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely pergolide (as pergolide mesilate) 1 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium anhydrous 25 microgram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely levothyroxine sodium anhydrous 25 microgram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely pergolide (as pergolide mesilate) 50 microgram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely pergolide (as pergolide mesilate) 50 microgram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely disopyramide (as disopyramide phosphate) 100 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely disopyramide (as disopyramide phosphate) 100 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely clopidogrel (as clopidogrel bisulfate) 75 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely clopidogrel (as clopidogrel bisulfate) 75 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline (as nortriptyline hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline (as nortriptyline hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	2
Product containing only tagraxofusp (medicinal product)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	2
Ruxolitinib (as ruxolitinib phosphate) 10 mg oral tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Ruxolitinib (as ruxolitinib phosphate) 10 mg oral tablet	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely loxapine (as loxapine succinate) 50 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely loxapine (as loxapine succinate) 50 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Product containing precisely darunavir (as darunavir ethanolate) 400 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Product containing precisely darunavir (as darunavir ethanolate) 400 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1 (kwalificatiewaarde)	Inferred relationship	Some
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	2
Product containing precisely cilazapril (as cilazapril monohydrate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1 (kwalificatiewaarde)	Inferred relationship	Some	1

Start Previous Page 168 of 215 Next End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
12718871000146116	1 (kwalificatiewaarde)	nl	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Netherlands NRC maintained module (core metadata concept)
12718881000146119	één	nl	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Netherlands NRC maintained module (core metadata concept)
13856651000146112	1	nl	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Netherlands NRC maintained module (core metadata concept)